Compare PUMP & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PUMP | ENOV |
|---|---|---|
| Founded | 2007 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Fluid Controls |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2017 | 2008 |
| Metric | PUMP | ENOV |
|---|---|---|
| Price | $7.25 | $21.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 13 |
| Target Price | $16.00 | ★ $36.08 |
| AVG Volume (30 Days) | ★ 4.1M | 1.2M |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.76 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,269,158,000.00 | N/A |
| Revenue This Year | N/A | $4.05 |
| Revenue Next Year | $16.07 | $4.89 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.91 | $16.70 |
| 52 Week High | $18.50 | $34.28 |
| Indicator | PUMP | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 21.73 | 61.63 |
| Support Level | N/A | $21.14 |
| Resistance Level | $12.29 | $26.97 |
| Average True Range (ATR) | 0.46 | 0.84 |
| MACD | -0.09 | 0.51 |
| Stochastic Oscillator | 7.62 | 89.07 |
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.